360 related articles for article (PubMed ID: 29463001)
1. The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer's Disease-Related Pathologies in APP/PS1 Transgenic Mice.
Tzeng TT; Chen CC; Chen CC; Tsay HJ; Lee LY; Chen WP; Shen CC; Shiao YJ
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463001
[TBL] [Abstract][Full Text] [Related]
2. Erinacine A-enriched Hericium erinaceus mycelium ameliorates Alzheimer's disease-related pathologies in APPswe/PS1dE9 transgenic mice.
Tsai-Teng T; Chin-Chu C; Li-Ya L; Wan-Ping C; Chung-Kuang L; Chien-Chang S; Chi-Ying HF; Chien-Chih C; Shiao YJ
J Biomed Sci; 2016 Jun; 23(1):49. PubMed ID: 27350344
[TBL] [Abstract][Full Text] [Related]
3. Erinacine S, a Rare Sesterterpene from the Mycelia of Hericium erinaceus.
Chen CC; Tzeng TT; Chen CC; Ni CL; Lee LY; Chen WP; Shiao YJ; Shen CC
J Nat Prod; 2016 Feb; 79(2):438-41. PubMed ID: 26807743
[TBL] [Abstract][Full Text] [Related]
4. Absolute Bioavailability, Tissue Distribution, and Excretion of Erinacine S in
Hu JH; Li IC; Lin TW; Chen WP; Lee LY; Chen CC; Kuo CF
Molecules; 2019 Apr; 24(8):. PubMed ID: 31022946
[TBL] [Abstract][Full Text] [Related]
5.
Tsai YC; Lin YC; Huang CC; Villaflores OB; Wu TY; Huang SM; Chin TY
J Med Food; 2019 May; 22(5):469-478. PubMed ID: 31084539
[TBL] [Abstract][Full Text] [Related]
6. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
[TBL] [Abstract][Full Text] [Related]
7. EK100 and Antrodin C Improve Brain Amyloid Pathology in APP/PS1 Transgenic Mice by Promoting Microglial and Perivascular Clearance Pathways.
Tsay HJ; Liu HK; Kuo YH; Chiu CS; Liang CC; Chung CW; Chen CC; Chen YP; Shiao YJ
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638752
[TBL] [Abstract][Full Text] [Related]
8. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
[TBL] [Abstract][Full Text] [Related]
9. Erinacine A-Enriched
Lee LY; Chou W; Chen WP; Wang MF; Chen YJ; Chen CC; Tung KC
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684662
[TBL] [Abstract][Full Text] [Related]
10. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.
Mao YF; Guo Z; Zheng T; Jiang Y; Yan Y; Yin X; Chen Y; Zhang B
Aging Cell; 2016 Oct; 15(5):893-902. PubMed ID: 27457264
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
12. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms.
Du Y; Qu J; Zhang W; Bai M; Zhou Q; Zhang Z; Li Z; Miao J
Neuropharmacology; 2016 Sep; 108():1-13. PubMed ID: 27067919
[TBL] [Abstract][Full Text] [Related]
13. Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.
Huang H; Nie S; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
Age (Dordr); 2016 Aug; 38(4):303-322. PubMed ID: 27439903
[TBL] [Abstract][Full Text] [Related]
14. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
15. Triptolide Rescues Spatial Memory Deficits and Amyloid-β Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
Cui YQ; Wang Q; Zhang DM; Wang JY; Xiao B; Zheng Y; Wang XM
Curr Alzheimer Res; 2016; 13(3):288-96. PubMed ID: 26906357
[TBL] [Abstract][Full Text] [Related]
16. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
18. A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model.
Zhu L; Yang JY; Xue X; Dong YX; Liu Y; Miao FR; Wang YF; Xue H; Wu CF
Mech Ageing Dev; 2015 Sep; 150():34-45. PubMed ID: 26200391
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
